This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potapova, O.
Right arrow Articles by Holbrook, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potapova, O.
Right arrow Articles by Holbrook, N. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2000, p. 1713-1722, Vol. 20, No. 5
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Inhibition of c-Jun N-Terminal Kinase 2 Expression Suppresses Growth and Induces Apoptosis of Human Tumor Cells in a p53-Dependent Manner

Olga Potapova,1 Myriam Gorospe,1 Ryan H. Dougherty,1 Nicholas M. Dean,2 William A. Gaarde,2 and Nikki J. Holbrook1,*

Cell Stress and Aging Section, Laboratory of Biological Chemistry, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224,1 and Isis Pharmaceuticals, Inc., Carlsbad, California 920082

Received 7 July 1999/Returned for modification 11 August 1999/Accepted 10 November 1999

c-Jun N-terminal kinase (JNK) plays a critical role in coordinating the cellular response to stress and has been implicated in regulating cell growth and transformation. To investigate the growth-regulatory functions of JNK1 and JNK2, we used specific antisense oligonucleotides (AS) to inhibit their expression. A survey of several human tumor cell lines revealed that JNKAS treatment markedly inhibited the growth of cells with mutant p53 status but not that of cells with normal p53 function. To further examine the influence of p53 on cell sensitivity to JNKAS treatment, we compared the responsiveness of RKO, MCF-7, and HCT116 cells with normal p53 function to that of RKO E6, MCF-7 E6, and HCT116 p53-/-, which were rendered p53 deficient by different methods. Inhibition of JNK2 (and to a lesser extent JNK1) expression dramatically reduced the growth of p53-deficient cells but not that of their normal counterparts. JNK2AS-induced growth inhibition was correlated with significant apoptosis. JNK2AS treatment induced the expression of the cyclin-dependent kinase inhibitor p21Cip1/Waf1 in parental MCF-7, RKO, and HCT116 cells but not in the p53-deficient derivatives. That p21Cip1/Waf1 expression contributes to the survival of JNK2AS-treated cells was supported by additional experiments demonstrating that p21Cip1/Waf1 deficiency in HCT116 cells also results in heightened sensitivity to JNKAS treatment. Our results indicate that perturbation of JNK2 expression adversely affects the growth of otherwise nonstressed cells. p53 and its downstream effector p21Cip1/Waf1 are important in counteracting these detrimental effects and promoting cell survival.

* Corresponding author. Mailing address: Laboratory of Biological Chemistry, GRC, NIA, 5600 Nathan Shock Dr., Box 12, Baltimore, MD 21224. Phone: (410) 558-8446. Fax: (410) 558-8386. E-mail: nikki_holbrook{at}nih.gov.

Molecular and Cellular Biology, March 2000, p. 1713-1722, Vol. 20, No. 5
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Wang, L., Zhang, Y., Li, H., Xu, Z., Santella, R. M., Weinstein, I. B. (2007). Hint1 Inhibits Growth and Activator Protein-1 Activity in Human Colon Cancer Cells. Cancer Res. 67: 4700-4708 [Abstract] [Full Text]  
  • Xia, D., Srinivas, H., Ahn, Y.-h., Sethi, G., Sheng, X., Yung, W. K. A., Xia, Q., Chiao, P. J., Kim, H., Brown, P. H., Wistuba, I. I., Aggarwal, B. B., Kurie, J. M. (2007). Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF{kappa}B-dependent Pathway. J. Biol. Chem. 282: 3507-3519 [Abstract] [Full Text]  
  • Li, Q.-P., Qi, X., Pramanik, R., Pohl, N. M., Loesch, M., Chen, G. (2007). Stress-induced c-Jun-dependent Vitamin D Receptor (VDR) Activation Dissects the Non-classical VDR Pathway from the Classical VDR Activity. J. Biol. Chem. 282: 1544-1551 [Abstract] [Full Text]  
  • Drinane, M., Walsh, J., Mollmark, J., Simons, M., Mulligan-Kehoe, M. J. (2006). The Anti-angiogenic Activity of rPAI-123 Inhibits Fibroblast Growth Factor-2 Functions. J. Biol. Chem. 281: 33336-33344 [Abstract] [Full Text]  
  • Bennett, B. L. (2006). c-Jun N-terminal kinase-dependent mechanisms in respiratory disease.. Eur Respir J 28: 651-661 [Abstract] [Full Text]  
  • Santos, C. R., Blanco, S., Sevilla, A., Lazo, P. A. (2006). Vaccinia Virus B1R Kinase Interacts with JIP1 and Modulates c-Jun-Dependent Signaling.. J. Virol. 80: 7667-7675 [Abstract] [Full Text]  
  • Li, X., Minden, A. (2005). PAK4 Functions in Tumor Necrosis Factor (TNF) {alpha}-induced Survival Pathways by Facilitating TRADD Binding to the TNF Receptor. J. Biol. Chem. 280: 41192-41200 [Abstract] [Full Text]  
  • Nishigaki, K., Hanson, C., Thompson, D., Yugawa, T., Ruscetti, S. (2005). Activation of the Jun N-Terminal Kinase Pathway by Friend Spleen Focus-Forming Virus and Its Role in the Growth and Survival of Friend Virus-Induced Erythroleukemia Cells. J. Virol. 79: 12752-12762 [Abstract] [Full Text]  
  • Suzuki, T., Moraes, T. J., Vachon, E., Ginzberg, H. H., Huang, T.-T., Matthay, M. A., Hollenberg, M. D., Marshall, J., McCulloch, C. A. G., Abreu, M. T. H., Chow, C.-W., Downey, G. P. (2005). Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells. Am. J. Respir. Cell Mol. Bio. 33: 231-247 [Abstract] [Full Text]  
  • Kuntzen, C., Sonuc, N., De Toni, E. N., Opelz, C., Mucha, S. R., Gerbes, A. L., Eichhorst, S. T. (2005). Inhibition of c-Jun-N-terminal-Kinase Sensitizes Tumor Cells to CD95-Induced Apoptosis and Induces G2/M Cell Cycle Arrest. Cancer Res. 65: 6780-6788 [Abstract] [Full Text]  
  • Ennis, B. W., Fultz, K. E., Smith, K. A., Westwick, J. K., Zhu, D., Boluro-Ajayi, M., Bilter, G. K., Stein, B. (2005). Inhibition of Tumor Growth, Angiogenesis, and Tumor Cell Proliferation by a Small Molecule Inhibitor of c-Jun N-terminal Kinase. J. Pharmacol. Exp. Ther. 313: 325-332 [Abstract] [Full Text]  
  • Reiley, W., Zhang, M., Sun, S.-C. (2004). Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD. J. Biol. Chem. 279: 55161-55167 [Abstract] [Full Text]  
  • Du, L., Lyle, C. S., Obey, T. B., Gaarde, W. A., Muir, J. A., Bennett, B. L., Chambers, T. C. (2004). Inhibition of Cell Proliferation and Cell Cycle Progression by Specific Inhibition of Basal JNK Activity: EVIDENCE THAT MITOTIC Bcl-2 PHOSPHORYLATION IS JNK-INDEPENDENT. J. Biol. Chem. 279: 11957-11966 [Abstract] [Full Text]  
  • Holzberg, D., Knight, C. G., Dittrich-Breiholz, O., Schneider, H., Dorrie, A., Hoffmann, E., Resch, K., Kracht, M. (2003). Disruption of the c-JUN-JNK Complex by a Cell-permeable Peptide Containing the c-JUN {delta} Domain Induces Apoptosis and Affects a Distinct Set of Interleukin-1-induced Inflammatory Genes. J. Biol. Chem. 278: 40213-40223 [Abstract] [Full Text]  
  • Vivo, C., Liu, W., Broaddus, V. C. (2003). c-Jun N-terminal Kinase Contributes to Apoptotic Synergy Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand plus DNA Damage in Chemoresistant, p53 Inactive Mesothelioma Cells. J. Biol. Chem. 278: 25461-25467 [Abstract] [Full Text]  
  • Zeng, L., Zhang, Y., Chien, S., Liu, X., Shyy, J. Y.-J. (2003). The Role of p53 Deacetylation in p21Waf1 Regulation by Laminar Flow. J. Biol. Chem. 278: 24594-24599 [Abstract] [Full Text]  
  • Zhang, H., Shi, X., Zhang, Q.-J., Hampong, M., Paddon, H., Wahyuningsih, D., Pelech, S. (2002). Nocodazole-induced p53-dependent c-Jun N-terminal Kinase Activation Reduces Apoptosis in Human Colon Carcinoma HCT116 Cells. J. Biol. Chem. 277: 43648-43658 [Abstract] [Full Text]  
  • Pipaon, C., Gutierrez, P., Montero, J. C., Lorenzo, M., Eguiraun, A., De la Fuente, J. A., Pandiella, A., Leon, J., Ortiz, J. M. (2002). Mitogen-activated Protein Kinase Routes as Targets in the Action of Diaza-anthracene Compounds with a Potent Growth-inhibitory Effect on Cancer Cells. Molecular Cancer Therapeutics 1: 811-819 [Abstract] [Full Text]  
  • Ma, X., Hu, J., Lindner, D. J., Kalvakolanu, D. V. (2002). Mutational Analysis of Human Thioredoxin Reductase 1. EFFECTS ON p53-MEDIATED GENE EXPRESSION AND INTERFERON AND RETINOIC ACID-INDUCED CELL DEATH. J. Biol. Chem. 277: 22460-22468 [Abstract] [Full Text]  
  • Potapova, O., Anisimov, S. V., Gorospe, M., Dougherty, R. H., Gaarde, W. A., Boheler, K. R., Holbrook, N. J. (2002). Targets of c-Jun NH2-terminal Kinase 2-mediated Tumor Growth Regulation Revealed by Serial Analysis of Gene Expression. Cancer Res. 62: 3257-3263 [Abstract] [Full Text]  
  • Shih, A., Davis, F. B., Lin, H.-Y., Davis, P. J. (2002). Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism. J. Clin. Endocrinol. Metab. 87: 1223-1232 [Abstract] [Full Text]  
  • She, Q.-B., Chen, N., Bode, A. M., Flavell, R. A., Dong, Z. (2002). Deficiency of c-Jun-NH2-terminal Kinase-1 in Mice Enhances Skin Tumor Development by 12-O-Tetradecanoylphorbol-13-Acetate. Cancer Res. 62: 1343-1348 [Abstract] [Full Text]  
  • Tawadros, T., Formenton, A., Dudler, J., Thompson, N., Nicod, P., Leisinger, H.-J., Waeber, G., Haefliger, J.-A. (2002). The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium. J. Cell Sci. 115: 385-393 [Abstract] [Full Text]  
  • Fan, M., Goodwin, M. E., Birrer, M. J., Chambers, T. C. (2001). The c-Jun NH2-terminal Protein Kinase/AP-1 Pathway Is Required for Efficient Apoptosis Induced by Vinblastine. Cancer Res. 61: 4450-4458 [Abstract] [Full Text]  
  • Buschmann, T., Potapova, O., Bar-Shira, A., Ivanov, V. N., Fuchs, S. Y., Henderson, S., Fried, V. A., Minamoto, T., Alarcon-Vargas, D., Pincus, M. R., Gaarde, W. A., Holbrook, N. J., Shiloh, Y., Ronai, Z.'e. (2001). Jun NH2-Terminal Kinase Phosphorylation of p53 on Thr-81 Is Important for p53 Stabilization and Transcriptional Activities in Response to Stress. Mol. Cell. Biol. 21: 2743-2754 [Abstract] [Full Text]  
  • Hreniuk, D., Garay, M., Gaarde, W., Monia, B. P., McKay, R. A., Cioffi, C. L. (2001). Inhibition of C-Jun N-Terminal Kinase 1, but Not c-Jun N-Terminal Kinase 2, Suppresses Apoptosis Induced by Ischemia/Reoxygenation in Rat Cardiac Myocytes. Mol. Pharmacol. 59: 867-874 [Abstract] [Full Text]  
  • Fan, M., Goodwin, M., Vu, T., Brantley-Finley, C., Gaarde, W. A., Chambers, T. C. (2000). Vinblastine-induced Phosphorylation of Bcl-2 and Bcl-XL Is Mediated by JNK and Occurs in Parallel with Inactivation of the Raf-1/MEK/ERK Cascade. J. Biol. Chem. 275: 29980-29985 [Abstract] [Full Text]  
  • Phelan, D. R., Price, G., Liu, Y. F., Dorow, D. S. (2001). Activated JNK Phosphorylates the C-terminal Domain of MLK2 That Is Required for MLK2-induced Apoptosis. J. Biol. Chem. 276: 10801-10810 [Abstract] [Full Text]  
  • Spiegelman, V. S., Stavropoulos, P., Latres, E., Pagano, M., Ronai, Z.'e., Slaga, T. J., Fuchs, S. Y. (2001). Induction of beta -Transducin Repeat-containing Protein by JNK Signaling and Its Role in the Activation of NF-kappa B. J. Biol. Chem. 276: 27152-27158 [Abstract] [Full Text]  
  • Potapova, O., Gorospe, M., Bost, F., Dean, N. M., Gaarde, W. A., Mercola, D., Holbrook, N. J. (2000). c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells. J. Biol. Chem. 275: 24767-24775 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»